麻豆传媒

More noteworthy research from the EASD 2024 meeting

Saxenda group six times more likely to lose at least 5% of BMI

No link found in nationwide data from Sweden and Denmark and in analysis of STEP trials

Similar improvements in weight loss and mental health in randomized trial

Reports of suicidal ideation higher when compared to other drugs in WHO database

Over 40% of pharmacy sites offering GLP-1 drug without a script are known to operate illegally

Multi-dose vials pose complications for self-administration

Stagnant screening practices reflect controversy over practice

Approximately one-fourth of new users in 2023 did not have type 2 diabetes

Physicians must work to break this cycle of bias

Prepare patients early for a time when medication is no longer an option

Moderate association between parental and offspring BMI at age 17

Childhood BMI nearly as important as adult BMI

Final recommendations did not include weight-loss drugs